APA (7th ed.) Citation

Urva, S., Quinlan, T., Landry, J., Martin, J., & Loghin, C. (2021). Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. Clinical pharmacokinetics, 60(8), 1049-1059. https://doi.org/10.1007/s40262-021-01012-2

Chicago Style (17th ed.) Citation

Urva, Shweta, Tonya Quinlan, John Landry, Jennifer Martin, and Corina Loghin. "Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide." Clinical Pharmacokinetics 60, no. 8 (2021): 1049-1059. https://doi.org/10.1007/s40262-021-01012-2.

MLA (9th ed.) Citation

Urva, Shweta, et al. "Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide." Clinical Pharmacokinetics, vol. 60, no. 8, 2021, pp. 1049-1059, https://doi.org/10.1007/s40262-021-01012-2.